Market Value7,867,925,000
Total Holdings108
File Date2014-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INCY / Incyte Corporation
AVNR / Avanir Pharmaceuticals Inc
XLRN / Acceleron Pharma Inc
/ Achaogen Inc
US00448Q2012 / Achillion Pharmaceuticals, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
AERI / Aerie Pharmaceuticals Inc
ALNY / Alnylam Pharmaceuticals, Inc.
02318X100 / Ambit Biosciences Corp
FOLD / Amicus Therapeutics, Inc.
032420101 / Anacor Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
/ Array BioPharma, Inc.
Arrowhead Research Corp. / (042797209)
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
AUXL / Auxilium Pharmaceuticals Inc
05334DAA5 / Auxilium Pharmaceuticals Inc 1.5% Bond due 2018-07-15
BDSI / Biodelivery Sciences International
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
VXRT / Vaxart, Inc.
XNCR / Xencor, Inc.
CLTX / Celsus Therapeutics
CHTP / Chelsea Therapeutics International, Ltd.
CLVS / Clovis Oncology Inc
CERS / Cerus Corporation
CYTR / LadRx Corp
DSCI / Derma Sciences, Inc.
WINT / Windtree Therapeutics, Inc.
DYAX / Dyax Corp.
ENTA / Enanta Pharmaceuticals, Inc.
EPZM / Epizyme Inc
HRTX / Heron Therapeutics, Inc.
INSM / Insmed Incorporated
IONS / Ionis Pharmaceuticals, Inc.
SGEN / Seagen Inc
IDRA / Idera Pharmaceuticals, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
ACOR / Acorda Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
US33830X1046 / Five Prime Therapeutics Inc
FURX / Furiex Pharmaceuticals, Inc.
GALT / Galectin Therapeutics Inc.
GHDX / Genomic Health, Inc.
GILD / Gilead Sciences, Inc.
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
AGIO / Agios Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
451731103 / Ignyta, Inc.
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
45337CAJ1 / Incyte Corporation Bonds 4.75% 10/1/2015
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
INFI / Infinity Pharmaceuticals Inc.
ICPT / Intercept Pharmaceuticals Inc
ITMN /
Intermune Inc Notes 5% 3/1/15 / CONV BONDS (45884XAD5)
Intermune Inc Notes 2.5% 12/15/17 / CONV BONDS (45884XAF0)
IRWD / Ironwood Pharmaceuticals, Inc.
KPTI / Karyopharm Therapeutics Inc.
KYTH / Kythera Biopharma
LJPC / La Jolla Pharmaceutical Co.
NLTX / Neoleukin Therapeutics, Inc.
LGND / Ligand Pharmaceuticals Incorporated
MGNX / MacroGenics, Inc.
SVRA / Savara Inc.
58501NAA9 / Medivation, Inc. 2.625% Bond 4/1/17
NBIX / Neurocrine Biosciences, Inc.
NVAX / Novavax, Inc.
OMER / Omeros Corporation
ISEE / IVERIC bio Inc
OSUR / OraSure Technologies, Inc.
OSIR / Osiris Therapeutics, Inc.
PCYC / Pharmacyclics
0PP / Portola Pharmaceuticals Inc
PGNX / Progenics Pharmaceuticals, Inc.
PBYI / Puma Biotechnology, Inc.
NVLN / NOVELION THERAPEUTICS INC.
QCOR /
RCPT / Receptos, Inc.
Regado / (75874Q107)
76028H209 / Repros Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
SLXP / Salix Therapeuticals, Inc.
Salix 2.75% 5/15/15 / CONV BONDS (795435AC0)
795435AE6 / Salix Pharmaceuticals Inc. Bond 1.5% 3/15/19
STML / Stemline Therapeutics, Inc.
GEVA / Synageva Biopharma Corp
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
ABUS / Arbutus Biopharma Corporation
TSRO / TESARO, Inc.
TGTX / TG Therapeutics, Inc.
MTEM / Molecular Templates, Inc.
VNDA / Vanda Pharmaceuticals Inc.
Ventrus Biosciences, Inc. / (922822101)
XNPT / XenoPort, Inc.
XOMA / XOMA Royalty Corporation
ZIOP / Alaunos Therapeutics Inc
ZGNX / Zogenix Inc
PRTA / Prothena Corporation plc
QURE / uniQure N.V.
MDGL / Madrigal Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
MRTX / Mirati Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
GERN / Geron Corporation
ACAD / ACADIA Pharmaceuticals Inc.